Oncogenic MicroRNAs: miR-155, miR-19a, miR-181b, and miR-24 enable monitoring of early breast cancer in serum

por Sochor, Marek, Basova, Petra, Pesta, Michal, Dusilkova, Nina, Bartos, Jiri, Burda, Pavel, Pospisil, Vit, Stopka, Tomas
Publicado 2014

Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas

por Dusílková, Nina, Bašová, Petra, Polívka, Jindřich, Kodet, Ondřej, Kulvait, Vojtěch, Pešta, Michal, Trněný, Marek, Stopka, Tomáš
Publicado 2017

Somatic mutation dynamics in MDS patients treated with azacitidine indicate clonal selection in patients-responders

por Polgarova, Kamila, Vargova, Karina, Kulvait, Vojtech, Dusilkova, Nina, Minarik, Lubomir, Zemanova, Zuzana, Pesta, Michal, Jonasova, Anna, Stopka, Tomas
Publicado 2017

G-CSF plus azacitidine versus azacitidine alone for patients with high-risk myelodysplastic syndrome: academic, open label, randomized trial

por Stopka, Tomáš, Minařík, Lubomír, Dusilková, Nina, Pešta, Michal, Kulvait, Vojtěch, Špaček, Martin, Zemanová, Zuzana, Kalousová, Marta, Jonášová, Anna
Publicado 2022

Analysis of 5-Azacytidine Resistance Models Reveals a Set of Targetable Pathways

por Minařík, Lubomír, Pimková, Kristýna, Kokavec, Juraj, Schaffartziková, Adéla, Vellieux, Fréderic, Kulvait, Vojtěch, Daumová, Lenka, Dusilková, Nina, Jonášová, Anna, Vargová, Karina Savvulidi, Králová Viziová, Petra, Sedláček, Radislav, Zemanová, Zuzana, Stopka, Tomáš
Publicado 2022